Target intelligence / Profile preview

Chromosome 6 open reading frame 141 (C6orf141)

Target
C6orf141
Molecular classification
Other (uncharacterized protein; not grouped as kinase, GPCR, transporter, ion channel, transcription factor, or histone modifier)
01

Overview

Chromosome 6 open reading frame 141 (C6orf141) is a small, uncharacterized human protein encoded on chromosome 6p12.3[1][4]. Its expression is broadly detected in normal tissues and is reduced in various cancer types, most notably in oral squamous cell carcinoma, where its low protein levels are associated with advanced tumor stage, nodal involvement, and poor prognosis[2][4]. Functional studies indicate that C6orf141 suppresses tumor proliferation, migration, and invasion in vitro and in vivo[4]. Its biological role may be context-dependent and is the subject of ongoing research in cancer biology, with explorations into its potential as a tumor suppressor and cancer biomarker[2][4]. No role as a canonical drug target, receptor, or enzyme is currently established[1][2][4][5].

Other names
C6orf141CF141MGC46457uncharacterized protein C6orf141
02

Mechanism of action

None established for drugs (not a known drug target)

03

Biological functions

Predicted involvement upstream of or within blastocyst hatching (developmental biology)Tumor suppression in oral squamous cell carcinoma: suppresses cancer cell proliferation, migration, invasion, and tumor growthMay affect chemo-responsiveness in triple-negative breast cancer via alternative splicing
04

Disease associations

Cancer (primarily as a candidate tumor suppressor in oral squamous cell carcinoma, potential roles in breast, thyroid, testicular, colon, lung, liver, and other cancers)Prognostic biomarker in oral cancer (and potentially as a biomarker of therapy response in breast cancer)
05

Safety considerations

None established, as it is not yet a therapeutic target; insufficient data
06

Biomarkers

Protein level of C6orf141 in tumor tissue: prognostic for oral squamous cell carcinoma (correlates with disease-specific survival and tumor aggressiveness)Exon‐specific expression associated with chemotherapy response in triple-negative breast cancer

Beyond the preview

Go deeper on Chromosome 6 open reading frame 141 (C6orf141).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Chromosome 6 open reading frame 141 (C6orf141).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call